U.S. market Closed. Opens in 1 day 5 hours 38 minutes

IPSC | Century Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue2.23M5.20MN/AN/AN/A
Cost of Revenue13.04M10.07M4.58M1.75M249.00K
Gross Profit-10.81M-4.87M-4.58M-1.75M-249.00K
Operating Expenses148.78M139.03M94.88M49.18M20.03M
Selling, General & Admin34.71M31.86M19.23M9.49M5.77M
Research & Development92.71M107.17M75.65M39.68M14.27M
Other Operating Expenses21.36M4.42M377.00K704.00K1.21M
Operating Income-146.55M-133.83M-94.88M-53.90M-245.98M
Other Expenses / Income11.75M2.99M-898.00K323.00K1.21M
Before Tax Income-134.79M-130.84M-95.78M-53.58M-244.77M
Income Tax Expenses1.88M91.00K43.00K1.08M1.21M
Net Income-136.67M-130.93M-95.82M-54.66M-245.98M
Interest Expenses540.00K1.10M1.27M381.00KN/A
Basic Shares Outstanding59.31M57.76M55.01M54.82M54.82M
Diluted Shares Outstanding59.31M57.76M55.01M54.82M54.82M
EBITDA-121.21M-119.34M-89.92M-51.44M-19.78M
EBITDA Margin-5,423.18%-2,295.44%0.00%0.00%0.00%
EBIT-134.25M-129.74M-94.51M-53.19M-244.77M
EBIT Margin-6,006.80%-2,495.40%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙